Market Overview

Brian Stutland Sees Unusual Options Activity In Juno Therapeutics


Brian Stutland spoke on CNBC's "Options Action" about a bullish options activity in Juno Therapeutics Inc (NASDAQ: JUNO).

He said that traders were selling puts and buying calls on a day when the stock spiked around 20 percent. Around 750 contracts of the September 42 puts were sold for $2.20 on Tuesday. There was also a big volume in the September 42.50 calls. Over 1,200 contracts were traded in the strike.

Stutland explained it seems that Gilead Sciences, Inc.'s (NASDAQ: GILD) acquisition of Kite Pharma Inc (NASDAQ: KITE) has increased the value of t-cell research.


Related Articles (JUNO)

View Comments and Join the Discussion!

Posted-In: Brian Stutland CNBC Options ActionOptions Markets Media